References
- LiangYWoodwardDFGuzmanVMIdentification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesBr J Pharmacol20081541079109318587449
- KitazawaYKomemushiSSingle-masked, randomized, parallel-group comparison of bimatoprost ophthalmic solution and latanoprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension [in Japanese]Atarashii Ganka201027401410
- DirksMSNoeckerRJEarlMRohSSilversteinSMWilliamsRDA 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaAdv Ther20062338539416912020
- NoeckerRSDirksMSChoplinNTBernsteinPBatoosinghALWhitcupSMBimatoprost/latanoprost study groupA six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol2003135556312504698
- BrandtJDVanDenburghAMChenKWhitcupSMBimatoprost study group 1Comparison of once-or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOPOphthalmology200110861023103111382623
- ParrishRKPalmbergPSheuW-PXLT study groupA comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol200313568870312719078
- BirtCMBuysYMAhmedIIKTropeGEthe Toronto area glaucoma societyProstaglandin efficacy and safety study undertaken by race (the pressure study)J Glaucoma20101946046720051890
- ManniGCentofantiMParravanoMOddoneFBucciMGA 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patientsGraefes Arch Clin Exp Ophthalmol200424276777015241611
- SharpeEDReynoldsACSkutaGLJenkinsJNStewartWCThe clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapyCurr Eye Res2007321037104318085467
- Latanoprost-induced iris pigmentation study groupIncidence of a latanoprost-induced increase in iris pigmentation in Japanese eyesJpn J Ophthalmol200650969916604382
- InoueKWakakuraMInoueJMatsuoHHaraTTomitaGAdverse reaction after use of latanoprost in Japanese glaucoma patients [in Japanese]Nippon Ganka Gakkai Zasshi200611058158716972649
- ShiokawaMInoueKHigaRAdverse reaction after use of benzalkonium chloride-free travoprost 0.004% in Japanese glaucoma or ocular hypertension patients [in Japanese]Atarashii Ganka20102714291434
- MasumotoMInoueKShiokawaMAdverse reaction after use of Tafluprost in Japanese glaucoma or ocular hypertension patients [in Japanese]Rinsho Ganka20116510891094
- YamJCYuenNSChanCWBilateral deepening of upper lid sulcus from topical bimatoprost therapyJ Ocul Pharmacol Ther20092547147219857110
- FilippopoulosTPaulaJSTorunNHattonMPPasqualeLRGrosskreutzCLPeriorbital changes associate with topical bimatoprostOphthal Plast Reconstr Surg200824302307
- PeplinskiLSSmithKADeepening of lid sulcus from topical bimatoprost therapyOptom Vis Sci20048157457715300114
- YangHKParkKHKimTWKimDMDeepening of eyelid superior sulcus during topical travoprost treatmentJpn J Ophthalmol20095317617919333704
- AydinSLşıklıgilLTekşenYKRecovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literatureCutan Ocul Toxicol20102921221620670089
- JayaprakasamAGhazi-NouriSPeriorbital fat atrophy- an unfamililiar side effect of prostaglandin analoguesOrbit20102935735921158579
- ParkJChoHKMoonJIChanges to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprostJpn J Ophthalmol201155222721331688